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Abstract
Background: Accumulating evidences indicate that non-coding RNAs (ncRNAs) including long non-coding RNAs
(lncRNAs) and microRNAs (miRNAs) acting as crucial regulators in osteosarcoma (OS). Previously, we reported that
Rho associated coiled-coil containing protein kinase 1 (ROCK1), a metastatic-related gene was negatively regulated
by microRNA-335-5p (miR-335-5p) and work as an oncogene in osteosarcoma. Whether any long non-coding RNAs
participate in the upstream of miR-335-5p/ROCK1 axial remains unclear.
Methods: Expression of differentiation antagonizing non-protein coding RNA (DANCR) and miR-335-5p/miR-1972 in
osteosarcoma tissues were determined by a qRT-PCR assay and an ISH assay. Osteosarcoma cells’ proliferation and
migration/invasion ability changes were measured by a CCK-8/EDU assay and a transwell assay respectively. ROCK1
expression changes were checked by a qRT-PCR assay and a western blot assay. Targeted binding effects between
miR-335-5p/miR-1972 and ROCK1 or DANCR were verified by a dual luciferase reporter assay and a RIP assay. In vivo
experiments including a nude formation assay as well as a CT scan were applied to detect tumor growth and
metastasis changes in animal level.
Results: In the present study, an elevated DNACR was found in osteosarcoma tissue specimens and in osteosarcoma cell
lines, and the elevated DNACR was closely correlated with poor prognosis in clinical patients. Functional experiments
illustrated that a depression of DANCR suppressed ROCK1-mediated proliferation and metastasis in osteosarcoma cells.
The results of western blot assays and qRT-PCR assays revealed that DANCR regulated ROCK1 via crosstalk with
miR-335-5p and miR-1972. Further cellular behavioral experiments demonstrated that DNACR promoted ROCK1-
meidated proliferation and metastasis through decoying both miR-335-5p and miR-1972. Finally, the outcomes of
in vivo animal models showed that DANCR promoted tumor growth and lung metastasis of osteosarcoma.
Conclusions: LncRNA DANCR work as an oncogene and promoted ROCK1-mediated proliferation and metastasis
through acting as a competing endogenous RNA (ceRNA) in osteosarcoma.
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Background
Osteosarcoma (OS) is a prevalent malignant bone tumor
whose predictive sites are metaphysis of long bones
among adolescents [1]. The character of fast growth and
early stage of metastasis takes the main charge for the
unfavorable prognosis of osteosarcoma [2]. As a result of
its vicious biological behavior, being present of pulmonary
metastasis is approximately 20% in the first visit of patients
[3]. Consequently, seeking out a crucial metastatic-related
molecular and identifying its underlying mechanism in
osteosarcoma are compelling needed.
Long non-coding RNAs (lncRNAs), which are a group of
transcribed RNA molecules and with length of more than
200 nucleotides, are involved in diverse biological processes
in tumor initiation, growth and metastasis through epigen-
etic, transcriptional and post transcriptional mechanisms
[4–6]. lncRNAs present multiple functions including post-
transcriptional regulation, chromatin modification in vari-
ous malignant tumors such as lung adenocarcinoma,
esophageal squamous cell carcinoma, renal cell carcinoma,
hepatocellular carcinoma and osteosarcoma [7–11]. Among
the working mechanisms of lncRNAs, competing endogen-
ous RNA (ceRNA) theory which was first proposed by
Leonardo Salmena received high recognition in noncoding
RNA area worldwide [12]. CeRNA theory hypothesizes that
RNA transcriptions includes lncRNAs communication
through a new “language” mediated by microRNA response
elements (MREs).
Previous studies by our group indicated that miR-335
functioned as a tumor suppressor by way of directly
targeting to its downstream gene - Rho associated
coiled-coil containing protein kinase 1 (ROCK1) [13,
14]. Here, we wondered whether lncRNA could interact
with miR-335 via the mechanism of ceRNA. Online pre-
diction driving differentiation antagonizing non-protein
coding RNA (DANCR) - a member of lncRNAs - to
arouse our attention for its similar MREs which might
be provided for miR-335-5p as ROCK1 did. Even further,
we found that DANCR and ROCK1 shared two MREs
for two miRNAs, miR-335-5p and miR-1972, respect-
ively. In the present study, we focused on the ceRNA
network which is comprising of DANCR, miR-335-5p/
miR-1972 and ROCK1, as well as explored the potential
effect of DANCR to ROCK1 - mediated proliferation
and migration/invasion in osteosarcoma.
Methods
Patients and tissue samples
Ninety-five cases of osteosarcoma tissues and matched
para-tumor tissues used in this study were collected
under the permissions of patients during tumorectomy
in Liaoning Cancer Hospital & Institute from February
2013 to September 2017. None of the patients had
received chemotherapy before surgery and all the 95
cases were diagnosed based on a definite pathological
diagnosis and the clinical stages of these patients were
determined according to the tumor.node.metastasis
(TNM) classification of the International Union Against
Cancer (UICC). Written informed consent was obtained
from all participants. The Institute Research Medical
Ethics Committee of Central Hospital affiliated to
Shenyang Medical College and Liaoning Cancer Hos-
pital & Institute granted approval for this study.
Cell culture
Human osteosarcoma cell lines MG-63, U2OS, MNNG/
HOS, 143B and human osteoblast cell line hFOB 1.19
were purchased from the Chinese Academy of Sciences
Cell Bank (Shanghai, China) and maintained in DMEM/
F12 (Gibco, El Paso, TX, USA), DMEM (Gibco), DMEM,
MEM, (Gibco) and DMEM, respectively. All mediums
were supplemented with 10% (v/v) fetal bovine serum
(FBS, Sigma, St. Louis, MO, USA), 100 IU/ml penicillin
(Baomanbio, China) and 100 mg/ml streptomycin
(Baomanbio, China). All osteosarcoma cell lines were
cultured at 37 °C in a humidified atmosphere con-
taining 5% CO2 while human osteoblast cell line
hFOB 1.19 was cultured at 34 °C with 5% CO2.
Plasmids and cell transfection
MiR-335-5p mimics, miR-1972 mimics, NC mimic, miR-
335-5p inhibitor, miR-1972 inhibitor and NC inhibitor were
purchased from Riobio (Ribobio, Guangzhou, China).
DANCR overexpression plasmids pcDNA-DANCR, wt-
DNACR-335, wt-DANCR-1972, mut-DANCR-335 and
mut-DANCR-1972 as well as DANCR and ROCK1 knock-
down plasmids DANCR shRNA and ROCK1 shRNA with
a corresponding negative control shRNA (NC shRNA)
were chemically synthesized by GenePharma (GenePharma,
Shanghai, China). The sequence of DANCR shRNA and
ROCK1 shRNA were listed in Additional file 1: Table S1.
Quantitative real-time PCR analysis was applied to detect
DANCR and ROCK1 expression level to value the silenced
efficiencies. The results were shown in Additional file 2:
Figure S2A, DANCR shRNA - 01 was selected as the
optimum shRNA in the subsequent experiments due to the
highest suppressive effect. ROCK1 shRNA-01 was selected
by the same means as presented in Additional file 2: Figure
S2B and was employed in following ROCK1 RNAi experi-
ment. The aforementioned plasmids were transfected into
MNNG/HOS and 143B cells by Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer’s protocol. For a stable cell transfection, cells were se-
lected by the culture medium containing 0.4 mg/ml
Geneticin (G418; Invitrogen). After 6 weeks, G418-resistant
cell clones were established.
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Reverse transcription and quantitative real-time PCR
The procedure was carried out as previously described
[15]. Total RNAs were extracted using Trizol reagent
(Invitrogen, Carlsbad, CA, USA). cDNAs were synthesis
by PrimeScriptTM RT reagent kit (Takara, Dalian,
China). qPCR was performed with the SYBR Premix Ex
Taq II kit (TaKaRa) and the Applied Biosystems 7500
Fluorescent Quantitative PCR system (Applied Biosys-
tems Life Technologies, USA). GAPDH and U6 were
used to normalize the expression levels of the DANCR/
ROCK1 and miR-335-5p/miR-1972, respectively. Primers
sequences were listed in Additional file 1: Table S1.
Western blot analysis
Total proteins were isolated using radio immunoprecipi-
tation assay (RIPA) lysis buffer (Sigma, St. Louis, MO,
USA) and qualified by BCA detecting kit (Keygen,
Nanjing, China) flollowing to the manufacture’s proto-
col. Proteins samples were subjected to 10% SDS-PAGE
and transferred onto a PVDF membrane, then incubated
with ROCK1 (Abcam, Cambridge, MA, UK; dilution
rates of 1:2000) and GAPDH antibodies (Abcam, dilu-
tion rates of 1:500) at 4 °C overnight, respectively. The
next day, the membranes were incubated with secondary
antibodies (Abcam, dilution rates of 1:2000) at room
temperature for 1 h. Protein bands were detected on X-ray
film via enhanced chemiluminescence detection system.
Cell proliferation assays
Osteosarcoma cells’ changes of proliferative capacity
were determined by 5-Ethynyl-20-Deoxyuridine (EDU)
incorporation assay and cell counting Kit-8 (CCK-8)
assay. For EDU incorporation assay, the procedure was
carried out according to the manufacturer’s instructions
with EDU detection kits (Keygen, Nanjing, China). CCK-
8 assay was executed as previously reported [16]. In
brief, osteosarcoma cells were seeded in 96-well plates
(2 × 103) supplemented with complete growth medium
and followed by different transfection 24 h later. At days
1, 2, 3, 4 and 5 after transfection, 10 μl CCK-8 solution
was added into each well and incubated for 2 h. The ab-
sorbance was measured at an optical density of 450 nm
using Microplate reader (Bio-Rad, CA, USA). Experi-
ments were repeated in triplicate.
Transwell assays
The procedure was carried out as previously described
[5]. In short, MNNG/HOS and 143B cells were seeded
on uncoated (for migration assays) and Matrigel-coated
(for invasion assays) upper chambers (BD Bioscience,
New Jersey, USA) respectively. Culture medium non-
containing and containing 10% FBS were supplemented
into the upper and lower wells respectively and incu-
bated for further 24 h. Followed by wiping of non-
migrated or non-invaded cells. Then the filters were
fixed in 90% ethanol and followed by crystal violet stain-
ing. Five random fields were counted per chamber by
using an inverted microscope (Olympus, Tokyo, Japan).
In situ hybridization assay and immunohistochemistry
analysis
In situ hybridization assay was performed on fresh
osteosarcoma tissue slices. In brief, slices were washed
with1× phosphate buffered saline (PBS)containing 0.5%
Triton X-100, afterwards be incubated with appropri-
ate amount of anti-DANCR, anti-miR-335-5p and
anti-miR-1972 oligodeoxy-nucleotide probes (RiboBio,
Guangzhou, China) with hybridization solution containing
1% blocking solution in humid chamber at 37 °C over-
night. The next day, slices were then washed three times
for 5 min each at 42 °C with 0.1% Tween-20 in 4× sodium
citrate buffer (SSC), once for 5 min in 2× SSC and once
for 5 min in 1× SSC in dark. Following, after be rinsed
with 1 × PBS for 5 min triply at room temperature and be
re-stained by DAPI (Cell Signaling Technologies, Danvers,
USA), fluorescent microscope (Leica, Wetzlar, Germany)
was applied to observe and photograph the slices. Images
were analyzed using Image - Pro Plus 6.0 software (Media
Cybernetics, Rockville, USA).
The procedure of immunohistochemistry was per-
formed as previously described [16].
Dual luciferase reporter assay
The procedure was carried out as previously described [10].
Wild and mutant reporter plasmids of DANCR (wt-
DANCR-335-luc, mut-DANCR-335-luc, wt-DANCR-1972-
luc and mut-DANCR-1972-luc) and ROCK1 (wt-ROCK1–
335-luc, mut-ROCK1–335-luc, wt-ROCK1–1972-luc and
mut-ROCK1–1972-luc) which containing a wild or mutant
miR-335-5p or miR-1972 binding sites were individually
synthesized by GenePharma (GenePharma, Shanghai,
China). When HEK293 cells achieved to 70% confluence,
the synthesized reporter plasmids were co-transfected with
miR-335-5p mimics/miR-1972 mimics or mimic control
respectively by Lipofectamine 2000 (Invitrogen). Forty-
eight hours later, the changes of the fluorescence in each
group were detected using Dual-Luciferase Reporter Assay
System (Promega, Madison, WI, USA) according to the
manufacturer’s protocol.
RNA immunoprecipitation (RIP) assay
The procedure was carried out as previously described
using Magna RNA-binding protein immunoprecipitation
kit (Millipore, Billerica, MA, USA) [17]. In brief, whole-cell
lysate was incubated with RIP buffer containing magnetic
beads conjugated with human anti-Ago2 antibody, or nor-
mal mouse IgG as negative control. Samples were incu-
bated with proteinase K and then immunoprecipitated
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RNA was isolated. The RNA concentration was measured
by spectrophotometer (Thermo Scientific, Waltham, MA,
USA) and the RNA quality was assessed with bio-analyzer
(Agilent, Santa Clara, CA, USA). Furthermore, purified
RNAs were extracted and analyzed by quantitative real-
time PCR to demonstrate the presence of binding targets.
In vivo nude mouse models
Female nude mice (4–5 weeks old) were purchased from
Animal Care and Use Committee of Dalian Medical Uni-
versity Ltd., and kept under sterile specific-pathogen-
free (SPF) conditions. 1 × 106 143B cells (mixed with
Matrigel, BD Bioscience, 1:1) with stable overexpression
of DANCR (DANCR puro) and with corresponding blank
vector (pMSCV puro) were injected subcutaneously or
intravenously for the determination of tumor growth and
metastasis. Tumor formation and metastasis were
monitored by Fluorescent Imager (IVIS Spectrum, Caliper
Life Sciences, Hopkinton, MA, once per week for
4 weeks) and Computed Tomography (CT, Siemens,
München, Germany, at week four) scan, respectively. The
subcutaneous formatted tumor nodes and the lungs from
metastatic group were harvested for further detection.
This study was carried out in accordance with the Guide
for the Care and Use of Laboratory Animals of the
National Institutes of Health and was granted by the
Institute Research Medical Ethics Committee of Central
Hospital affiliated to Shenyang Medical College.
Statistical analysis
The significance of differences between groups was
assessed by Student’s t-test, one-way ANOVAs or χ2 test,
as appropriate. Survival curves were estimated by the
Kaplane-Meier method. The log-rank test was used to
determine the statistical differences between survival
curves. All statistical analyses were performed using
GraphPad Prism V5.0 (GraphPad Software, Inc., La Jolla,
CA, USA) and SPSS 19.0 (IBM, SPSS, Chicago, IL,
USA). A two-tailed P < 0.05 was considered as statisti-
cally significant while P < 0.01 was very significant.
Results
DANCR was elevated in osteosarcoma tissues and cell
lines and was correlated with poor prognosis in
osteosarcoma patients
The expression of DANCR in collected 95 cases of osteo-
sarcoma tissues and matched para-tumor tissues were
determined by applying of quantitative real-time PCR
(qRT-PCR) as normalizing to GAPDH. As the results
presented in Fig. 1a, DANCR was elevated in most osteo-
sarcoma tissues (72/95, 75.79%) when compared with
para-tumor tissues. Additionally, the potential correlation
between expression level of DANCR and clinicopathologi-
cal features were uncovered. As the outcomes displayed in
Fig. 1b-d, the expression of DNACR was notably higher in
patients with advanced stage, lymph node metastasis and
distant metastasis. Meanwhile, further analysis by Pearson
Chi-Square test or Fisher’s Exact Test indicated higher ex-
pression of DANCR was correlated with bigger tumor size
(≥ 5 cm), advanced staging (IIB/III) and distant metastasis
(Table 1). Moreover, In situ hybridization (ISH) analysis
was applied to evaluate the expression of DANCR in tis-
sue level. As shown in Fig. 1e, DANCR was gradually
strongly stained with staging in osteosarcoma tissues than
that in para-tumor tissues. Also, DANCR was intensively
stained in osteosarcoma cells’ cytoplasm. Even further, the
expression level of DANCR in 4 osteosarcoma cell lines
MG-63, U2OS, MNNG/HOS, 143B and a normal human
osteoblastic cell line hFOB 1.19 were also measured by
qRT-PCR. As was illustrated in Fig. 1f, the expression of
DANCR was significantly elevated in osteosarcoma cell
lines MG-63, U2OS, MNNG/HOS, 143B compared to
that in hFOB 1.19. Finally, Kaplan-Meier analysis and log-
rank test were used to evaluate the correlation between
the elevated DANCR and the final survival time of osteo-
sarcoma patients. The results in Fig. 1g suggested that
high DANCR expression was inversely correlated with
osteosarcoma patients’ overall survival.
DANCR promoted proliferation and migration/invasion in
MNNG/HOS and 143B cells
Since DANCR was highly expressed in osteosarcoma and
was correlated with tumor size and distant metastasis in
clinical cases, we wondered about the function DANCR
might act on osteosarcoma cells’ proliferation and metasta-
sis. Up-regulation and down-regulation of DANCR by
transfection of DANCR-shRNA and pcDNA-DANCR
respectively were confirmed by qRT-PCR (Fig. 2a-b). Then,
5-ethynyl-2′-deoxyuridine (EdU) incorporation assays and
CCK-8 assays were applied to evaluate the effects of
DANCR on cell proliferation in osteosarcoma cells
MNNG/HOS and 143B. As was presented in Fig. 2c-d,
DANCR confidently enhanced the proliferative capacity in
MNNG/HOS and 143B cells, and vice versa. In addition,
the migration/invasion ability changes in MNNG/HOS and
143B cells were determined by transwell assay. As was
shown in Fig. 2e-f, depression and elevation of DANCR also
positively regulated osteosarcoma cells’ migration/invasion.
DANCR promoted proliferation and migration/invasion
via up-regulation of ROCK1 in MNNG/HOS and 143B cells
Increasing evidences demonstrated that lncRNAs regulated
various downstream genes to exert multiple functions.
According to our and other previous researches, ROCK1
was closely related to osteosarcoma cells’ proliferation and
migration/invasion [5, 18]. Here, we attempted to figure
out whether the regulation effect of DANCR on osteosar-
coma cells’ proliferation and migration/invasion was
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achieved through ROCK1. We firstly demonstrated that
ROCK1 was elevated in osteosarcoma tissue specimens and
in osteosarcoma cell lines (Fig. 3a-b). Also, we displayed the
positive correlation between DANCR and ROCK1 (Fig. 3c).
We then confirmed that up- and down-regulation of
DANCR could positively affected ROCK1 expression both
in mRNA and in protein level (Fig. 3d-e). Furthermore, we
determined the role which ROCK1 might play in DANCR-
related proliferation and migration/invasion. As the results
presented in Fig. 3f-g, knockdown of ROCK1 (co-transfec-
tion of pcDNA-DANCR and ROCK1 shRNA) attenuated
the proliferating-assisted effect DANCR in MNNG/HOS
and 143B cells. Meanwhile, transwell assay elucidate a simi-
lar tendency of ROCK1 performing on migration/invasion
as it did on proliferation (Fig. 3h-i).
DANCR up-regulated ROCK1 via crosstalk with miR-335-5p
and miR-1972
Lately, researches on the competitive endogenous RNA
(ceRNA) theory between lncRNAs and miRNAs are the
hotspots in the field of noncoding RNAs. Therefore, we
specuated whether DANCR might crosstalk with any po-
tential miRNAs in dependence of the same mechanism
in osteosarcoma. Firstly, an online lncRNA prediction
software (DIANA-LncBase) was applied to predict the
potential miRNAs that might interact with DANCR.
Among the top 18 miRNAs of which the predictive
binding scores were higher than 0.9 (Additional file 3:
Figure S1), miR-335-5p and miR-1972 stroke our sight
because DANCR and ROCK1 shared the similar miRNA
response elements (MREs) for miR-335-5p and miR-
1972 (Fig. 4a, predicted by DIANA-LncBase and Tar-
getScan). Secondly, the expression of miR-335-5p and
miR-1972 in osteosarcoma tissues and cell lines were
determined by ISH and qRT-PCR. As was shown in
Fig. 4b-c, miR-335-5p and miR-1972 were lower
expressed in osteosarcoma tissue and cell lines, individually.
And this lower expression level of miR-335-5p and miR-
1972 indirectly provided the possibility that DANCR might
co-work with them in the progression of osteosarcoma.
Fig. 1 a DANCR expression in 95 cases of osteosarcoma tissues and paired para-tumor tissues were determined by using of qRT-PCR, data were
shown as log2 (2
-△△Ct). b-d DANCR expression was significantly elevated in patients with advanced stage (b) (***, P < 0.001,****, p < 0.0001), lymph
node metastasis (c) (**, P < 0.01,***, P < 0.001,) and distant metastasis (d) (**, P < 0.01,***, P < 0.001, ###, P < 0.001, respectively) with data be shown
as △Ct. e DANCR expression was gradually elevated with advanced staging as detected by In situ hybridization analysis, **, P < 0.01, ***, P < 0.001,
as comparing with para-tumor tissue group, respectively. f Elevated DANCR was presented in osteosarcoma cell lines contrasted to hFOB 1.19
group, data was normalized to hFOB 1.19 group, ***, P< 0.001. g Kaplan-Meier analyses indicated that overall survival (OS) in the patients with high DANCR
was significantly shorter than that in the patients with low DANCR, P= 0.02. Data were shown as mean ± SD from three independent experiments
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Thirdly, inverse correlations between DANCR and miR-
335-5p as well as DANCR and miR-1972 were presented
by Pearson correlation analysis in the collected 95 cases of
osteosarcoma tissues (Fig. 4d-e). We then verified that in-
crease or decrease DANCR negatively regulated miR-335-
5p and miR-1972 (Fig. 4f-g). Conversely, up-regulated and
down-regulated miR-335-5p and miR-1972 also inversely
affected in DANCR expression (Fig. 4h-i). These outcomes
indicated that DNACR can “crosstalk” with miR-335-5p
and miR-1972 in a reciprocal suppression manner. MiR-
NAs are well known to regulate targeted downstream genes
by directly binding to the 3′ untranslated regions (3′UTRs)
[19–21]. So, we further proved that miR-335-5p and miR-
1972 could negatively regulate ROCK1 mRNA expression
and that ROCK1 was a direct target of miR-335-5p and
miR-1972 (Fig. 4j-m). Finally, miR-335-5p and miR-1972
mimics were used to detect the effect they might execute
on DANCR-induced ROCK1 elevation. As we expected,
opposite to NC mimic, miR-335-5p mimics and miR-1972
mimics attenuated DANCR induced ROCK1 elevation
(Fig. 4n-o). Together, the evidence in this section
demonstrated that DANCR promoted ROCK1 expres-
sion via “crosstalk” with miR-335-5p and miR-1972.
DANCR decoyed miR-335-5p and miR-1972 to facilitate
ROCK1-mediated proliferation and migration/invasion
In the above sections, we verified that DANCR could
“crosstalk” with miR-335-5p and miR-1972 and pro-
moted ROCK1-mediated proliferation and migration/in-
vasion. In this section, we tried to elucidate whether the
ceRNA mechanism do exist among DANCR, miR-335-
5p/miR-1972 and ROCK1. We had proved that DANCR
affected miR-335-5p and miR-1972 with a reciprocal
suppression manner in the previous section, we here ap-
plied a luciferase assay to detect the specific binding
sites between DNACR and miR-335-5p/miR-1972. As
the results showed in Fig. 5b-c, compare to NC mimic,
cotransfection of miR-335-5p or miR-1972 mimics and
wt-DANCR led to a prominent decrease of fluorescence.
When the theoretical binding sites DANCR might pro-
vide for miR-335-5p or miR-1972 were mutated (cotran-
fection of miR-335-5p mimics and wt-DANCR-335 or
cotransfection of miR-1972 mimics and wt-DANCR-
1972), the fluorescence was restrengthened. Further, as
the outcomes of a RIP binding assay presented, the level
of DANCR and miR-335-5p/miR-1972 was higher in
anti-Ago2 group than that in anti-normal IgG group
which indicating that DANCR and miR-335-5p/miR-
1972 were in the same RNA induced silencing complex
(RISC) (Fig. 5d-e). Combined with the findings above,
we believed that DANCR decoyed miR-335-5p and miR-
1972 to promote their common-target gene - ROCK1.
Furthermore, an antisense experiment was executed to
final support the hypothesis that DANCR improved
ROCK1-mediated proliferation and migration/invasion
via directly decoying of miR-335-5p and miR-1972 in
osteosarcoma cells.
Elevation of DANCR promoted tumorigenesis and lung
metastasis of osteosarcoma in vivo
In this section, orthotopic xenograft mouse models were
introduced to finally confirm the facilitative effect
DANCR conducts on tumor growth and lung metastasis
of osteosarcoma. As was shown in Fig. 6a-b, overexpres-
sion of DNACR (DANCR puro) significantly promoted
tumor growth of ostesoacoma as comparing with blank
vector (pMSCV puro) group. Meanwhile, consequence
that elevated DANCR but depressed miR-335-5p and
miR-1972 in DANCR puro group was noticed by a qRT-
PCR detection (Fig. 6e-g). Also, ROCK1 expression in
the formatted subcutaneous nudes were determined by
IHC and western blot. Data presented in Fig. 6c implied
elevation of DNACR could promote ROCK1 expression.
Further, at the fourth week after caudal vein injection,
the metastatic nudes in lungs were determined by CT
Table 1 Association of DANCR expression with clinicopathological
features of osteosarcoma
Features No.
of
cases
DANCR p value†
High Low
Age at diagnosis 0.481
<18 52 40 12
≥18 43 32 11
Gender 0.472
Female 51 38 13
Male 44 34 10
Histological subtype 0.674
Osteoblastic 9 6 3
Chondroblastic 18 12 6
Fibroblastic 38 30 8
Mixed 30 24 6
Clinical stage 0.005
I + IIA 42 26 16
IIB/III 53 46 7
Distant metastasis 0.002
Absent 37 22 15
Present 58 50 8
Tumor size (cm) 0.014
<5 39 23 16
≥ 5 56 49 7
Anatomic location 0.431
Tibia/femur 49 38 11
Elsewhere 46 34 12
†P-value obtained from Pearson Chi-Square test or Fisher’s Exact Test
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scan. As the representative images displayed in Fig. 6h,
up-regulating DANCR also contributed to lung metasta-
sis of osteosarcoma in mice. Finally, as the detective re-
sults of metastatic nodes in lung demonstrated in Fig. 6i-n,
increasing DNACR boosted ROCK1 expression but inhib-
ited miR-335-5p and miR-1972 expression. Together, the
indication of this part confirmed that elevation of DANCR
promoted tumorigenesis and lung metastasis of osteosar-
coma in vivo.
Discussion
Recently, aberrant expression of some lncRNAs has been
elucidated as functioning multiple effects in tumorgen-
esis of osteosarcoma [22–25]. DANCR is located in hu-
man chromosome 4q12, and is reported as an oncogene
in diverse carcinomas. Yuan SX suggested that DANCR
increased stemness features of hepatocellular carcinoma
by derepression of catenin beta 1 (CTNNB1) [26]. Jia J
persisted that DANCR promoted the invasion ability of
C4-2B and CW22RV1 cells through epigenetically silen-
cing TIMP2/3 expression in a research of prostate can-
cer [27]. To date, related researches on DNACR and
osteosarcoma were rare. Jiang N revealed that DANCR
could enhance tumor progression and cancer stemness
features in osteosarcoma by upregulating AXL via miR-
33a-5p inhibition [28]. In the present study, we took
DANCR as a study target based on the previous research
foundation. We found that DANCR was raised in osteo-
sarcoma cell lines and in osteosarcoma tissue specimens
especially in specimens with late staging, lymph node
Fig. 2 a-b Over-expression and knockdown of DANCR in MNNG/HOS (a) and 143B (b) cells were confirmed by qRT-PCR. c-d EDU assay and CCK-8
assay were performed to determine the cell proliferation changes after DANCR up- and down-regulation in MNNG/HOS (c) and 143B (d) cells. e-f
Transwell assay was applied to evaluate the migration/invasion ability changed after DANCR regulation in MNNG/HOS (e) and 143B (f) cells. **, P < 0.01
and ##, P < 0.01, normalized to NC-shRNA and pcDNA group, respectively. Data were shown as mean ± SD from three independent experiments
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metastasis and distant metastasis. Also, we validated that
elevated DANCR was closely correlated with a short sur-
vival time in patients. These data indicated that DANCR
works as an oncogene in the progression of osteosar-
coma. In the part of clinical detection, a total of 95 pa-
tients were involved in our research. The sample size is
big enough to illustrate the role of DNACR playing in
osteosarcoma. According to the outcomes of clinical de-
tection, the further cellular level of EDU and transwell
assays primarily reinforced that DANCR promoted
osteosarcoma cells’ proliferation and metastatic abilities.
Therefore, exploring out the detailed mechanism of how
DANCR working is meaningful.
LncRNAs are reported to regulate gene expression and
chromatin structure via following ways: decoy effect,
scaffold effect and post-transcriptional effect [29]. In
2011, the ceRNA theory was firstly proposed by
Leonardo Salmena and was extensively accepted in non-
coding RNA area. Numerous researches on ceRNA and
cancers were explored [30–36]. In our previous studies,
we found that miR-335-5p suppressed osteosarcoma
cells’ metastatic ability via targeting its downstream gene
ROCK1 [14, 37]. ROCK1 was also broadly reported as a
proliferation- and metastasis-related gene in various can-
cers [38–41]. Hence, we tried to elucidate whether
DNACR could affect ROCK1 and its mediated prolifera-
tion and metastasis via a same mechanism as ceRNA. As
the first encouraging result, we verified that DANCR did
promote osteosarcoma cells’ proliferation and metastasis
via up-regulation of ROCK1. According to the previous
researches, ROCK1 could be targeted by many miRNAs
[41–44]. Also, it is well known that lncRNA can regulate
numbers of miRNAs at the same time, and one miRNA
can regulate an army of downstream target genes. We
therefore wondered whether DNACR could co-work
with one or more miRNAs to regulate ROCK1-mediated
proliferation and metastasis. As a bright result, we found
that DANCR and ROCK1 not only shared a similar
Fig. 3 a The elevated expression of ROCK1 in tissue level were displayed by an IHC detection, ***, P< 0.001, normalized to para-tumor tissue group. b
ROCK1 was up-regulated in osteosarcoma tissue and cell lines as determined by a qRT-PCR, **, P< 0.01 and ##, P< 0.01, normalized to para-tumor tissue
group and hFOB 1.19 group, respectively. c A positive correlations between DNACR and ROCK1 was confirmed by a Pearson correlation
analysis, P < 0.0001. d-e The expression of ROCK1 after DANCR regulation were measured by using of qRT-PCR (d) and western blot (e) in
MNNG/HOS and 143B cells, separately. f-g RNAi technique was used to define the function ROCK1 might work on DANCR induced proliferation. Silencing
ROCK1 by transfection of ROCK1 shRNA attenuated DANCR-induced facilitation of proliferation in MNNG/HOS (f) and 143B (g) cells, as determined by an
EDU assay. h-i A transwell assay was executed to verify the role of ROCK1 in DANCR-induced metastasis in MNNG/HOS (h) and 143B (i) cells. **, P< 0.01,
normalized to pcDNA-DANCR + NC shRNA group. Data were shown as mean ± SD from three independent experiments
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Fig. 4 a DANCR and ROCK1 shared two similar MREs for miR-335-5p and miR-1972 as predicted by DIANA-LncBase (http://carolina.imis.athena-innova-
tion.gr) and TargetScan (http://www.targetscan.org/vert_71), individually. b miR-335-5p and miR-1972 in tissue level were detected by using ISH, **,
P < 0.01, normalized to para-tumor tissue group. c The expression of miR-335-5p and miR-1972 in osteosarcoma tissue and cell lines were assessed by
qRT-PCR, ##, P < 0.01 and **, P < 0.01 as normalized to para-tumor tissue group and hFOB 1.19 group, separately. d-e Correlations between DNACR and
miR-335-5p (d) as well as DANCR and miR-1972 (e) were qualified by a Pearson correlation analysis, P < 0.0001 for miR-335-5p and P = 0.0009 for
miR-1972, respectively. f-g A qRT-PCR assay verified that increased or reduced DNACR negatively regulated miR-335-5p (f) and miR-1972 (g) expression,
**, P < 0.01 and ##, P < 0.01 as normalized to pcDNA group and NC shRNA group. h-i An elevation and a depression of miR-335-5p (h) and miR-1972
(i) also inversely regulated DANCR expression, separately. Determined by qRT-PCR, **, P < 0.01 and ##, P < 0.01 as normalized to mimic control group
and inhibitor control group. j-m Up-regulation or down-regulation of miR-335-5p (j and l) and miR-1972 (k and m) functioned on ROCK1 expression
inversely as measured by qRT-PCR and western blot. **, P < 0.01 and ##, P < 0.01 as normalized to mimic control group and inhibitor control
group. p-s Elevation of miR-335-5p and miR-1972 significantly attenuated the facilitative effect of DANCR on ROCK1 expression as determined
by qRT-PCR (p and q) and western blot (r and s) in MNNG/HOS and 143B cells, respectively. **, P < 0.01, normalized to pcDNA-DANCR group. Data
were shown as mean ± SD from three independent experiments
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MREs for miR-335-5p but also shared another MREs for
miR-1972. Meanwhile, we revealed the negative correl-
ation between DNACR and miR-335-5p and miR-1972
by a Pearson correlation analysis, respectively. Further, a
series of up and down functional experiments clear dem-
onstrated the reciprocal suppressive effect between
DNACR and miR-335-5p and miR-1972 respectively
which indicating that DANCR could crosstalk with these
two miRNAs. It is widely accepted that miRNAs regu-
lated their target genes by directly binding. We here de-
signed a luciferase assay and a RIP binding assay to
confirm the targeted binding effect between DANCR/
Fig. 5 a Sequence alignment of DANCR with potential wild type and mutant type of miR-335-5p (wt-DANCR-335 and mut-DANCR-335) and miR-1972
(wt-DANCR-1972 and mut-DANCR-1972) targeting sites. b-c Luciferase reporter assay was applied to verify the targeted binding effect between DANCR 3′
UTR and miR-335-5p or miR-1972, **, P< 0.01, as compared and normalize to mimic control group, respectively. d-e RIP binding assay was performed using
input from cell lysate, normal mouse IgG or anti-Ago2. Relative expression levels of DANCR and miR-335-5p or miR-1972 were determined by qRT-PCR.
**P< 0.01 vs anti-normal IgG group. f-i A re-executed CCK-8 and EDU assay presented that promotion of miR-335-5p or miR-1972 (transfection of miR-335-
5p mimics or miR-1972 mimics) led to significantly suppression of proliferation, while the suppressive effect was reversed by wt-DANCR but not be done
by mut-DANCR-335 or mut-DANCR-1972. j-k Re-executed transwell assay also demonstrated that it was wt-DANCR that can attenuate miR-335-5p- or miR-
1972-induced inhibition of metastasis, when the theoretical binding sites DANCR might provide for miR-335-5p or miR-1972 were mutated, the reversing
effect vanished. For F-K, data were normalized to NC mimic group, and **P< 0.01, & P> 0.05 as comparing with miR-335-5p mimics group or miR-1972
mimics group, respectively. Data were shown as mean ± SD from three independent experiments
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Fig. 6 a-b Representative photographs of IVIS images (a), macroscopic appearance (b up) and growth curve (b down) strongly indicated that elevated
DANCR (DANCR puro) promoted tumorigenesis opposite to pMSCV puro group. c, e-g Elevation of DANCR (e, confirmed by qRT-PCR) enhanced ROCK1 (c,
detected by IHC and western blot, scale bars 50 μm) but restricted miR-335-5p (f, detected by qRT-PCR) and miR-1972 (g, detected by qRT-PCR) expression in
the formatted subcutaneous nudes. d h & e staining demonstrated the formation of osteosarcoma nodules, scale bars, 200 μm and 50 μm for magnifications
of 100× and 400×, respectively. h-i Elevation of DANCR led to promotion of lung metastasis of osteosarcoma which were presented by the representative
photographs of CT scan, macroscopic appearance and HE staining (scale bars 200 μm, magnifications of 100×). j Elevated expression of DANCR in DANCR
puro group was confirmed by qRT-PCR detection compared to pMSCV puro group. k-n Elevation of DNACR suppressed miR-335-5p (k, detected by qRT-
PCR) and miR-1972 (l, detected by qRT-PCR) but improved ROCK1 (m by IHC, scale bars 50 μm, and N by western blot detection) expression in formatted
metastatic nudes. All data were normalized to pMSCV puro group, **P< 0.01 as comparing to pMSCV puro group. Data were shown as mean± SD from
three independent experiments
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ROCK1 and miR-335-5p/miR-1972 in molecular level,
respectively. Convincingly, the constructed luciferase
assay and RIP binding assay certified that both DANCR
and ROCK1 were the targets of miR-335-5p/miR-1972.
In addition, an executed antisense experiment strongly
stated that it was wild DANCR cDNA but not mutant
DNACR cDNA could reverse the suppressive effect on
proliferation and metastasis which was caused by eleva-
tion of miR-335-5p or miR-1972. Finally, in an in vivo
animal study, we verified again that DNACR positively
triggered tumor growth and lung metastasis in mice. To-
gether, as the schematic diagram presented in Fig. 7, we
drew the conclusion that DANCR promoted ROCK1-
mediated proliferation and metastasis by acting as a
ceRNA via decoying of miR-335-5p and miR-1972 in
osteosarcoma.
The development and progression of osteosarcoma is
a very complicated biological process which including an
ocean of molecules and multiple mechanisms. The
ceRNA network which are comprised by DNACR, miR-
335-5p/miR-1972 and ROCK1 is a hidden corner of ice-
berg in osteosarcoma. We have reasons to believe that
numerous genes and downstream targets of DANCR are
still worthy of further exploring.
Conclusions
The present study firstly demonstrated that DANCR
could decoy two miRNAs – miR-335-5p and miR-1972
to facilitate ROCK1-mediated proliferation and metasta-
sis via a ceRNA network. This provide a novel target
and a better understanding for possibly potential mech-
anism of pathogenesis and molecular therapeutic strat-
egy for osteosarcoma.
Additional files
Additional file 1: Table S1. The sequences of primers used in this work.
(DOCX 18 kb)
Additional file 2: Figure S2. The silenced efficiencies of DANCR and
ROCK1 knock down plasmids were qualified by a qRT-PCR assays, and
DANCR shRNA-01 as well as ROCK1 shRNA-01 were selected in the
following RNAi experiments. (JPG 722 kb)
Additional file 3: Figure S1. DIANA TOOLS was applied to predict the
potential miRNAs that might interact with DANCR, and the top 18
miRNAs were demonstrated for their higher theoretical binding scores
(higher than 0.900). (JPG 3899 kb)
Abbreviations
3′-UTR: 3′-untranslated region; CeRNA: Competing endogenous RNA;
DANCR: Differentiation antagonizing non-protein coding RNA;
LncRNAs: Long non-coding RNAs; MiRNAs: microRNAs; MREs: miRNA
Fig. 7 Schematic diagram of mechanism on this research. DANCR promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p
and miR-1972 in osteosarcoma
Wang et al. Molecular Cancer  (2018) 17:89 Page 12 of 14
response elements; RIP assay: RNA immunoprecipitation assay; ROCK1: Rho
associated coiled-coil containing protein kinase 1
Funding
This work was supported by grants from National Natural Science
Foundation of China (No 81502333).
Authors’ contributions
YW and XZ conceived the experiments; NW, YZ and ZL performed the
experiments; YW, WZ and ST analyzed the data; YW and XZ wrote the
manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
All osteosarcoma tissues and matched para-tumor tissues were in accordance
with the ethical guidelines of Liaoning Cancer Hospital & Institute and the
Helsinki declaration. The ethics consents were signed by each patient before
the study. All patients agreed that the data from their samples could be used
for experimental studies and paper presentations.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
14th Department of Orthopedic Surgery, Central Hospital affiliated to
Shenyang Medical College, No.5, South Seven West Road, Tiexi District,
Shenyang, Liaoning 110024, People’s Republic of China. 2Department of
Surgical Oncology, Central Hospital affiliated to Shenyang Medical College,
Shenyang, People’s Republic of China. 32nd Department of Cardiology,
Central Hospital affiliated to Shenyang Medical College, Shenyang, People’s
Republic of China. 4Institute for Cardiovascular Prevention,
Ludwig-Maximilians-University, Munich, Germany. 51st Department of Hand
Surgery, Central Hospital affiliated to Shenyang Medical College, Shenyang,
People’s Republic of China. 6Department of Pathology, Liaoning Cancer
Hospital & Institute, Shenyang, People’s Republic of China. 7Department of
Nuclear Medicine, The First Affiliated Hospital of Dalian Medical University,
Dalian 116011, People’s Republic of China.
Received: 17 February 2018 Accepted: 25 April 2018
References
1. Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bohler PJ,
Bruland OS. Time-trends on incidence and survival in a nationwide and
unselected cohort of patients with skeletal osteosarcoma. Acta oncologica
(Stockholm, Sweden). 2015;54(1):25–33.
2. Sampo M, Koivikko M, Taskinen M, Kallio P, Kivioja A, Tarkkanen M, Bohling
T. Incidence, epidemiology and treatment results of osteosarcoma in
Finland - a nationwide population-based study. Acta oncologica
(Stockholm, Sweden). 2011;50(8):1206–14.
3. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res.
2009;152:3–13.
4. Han Li C, Chen Y. Small and long non-coding RNAs: novel targets in
perspective cancer therapy. Curr Genomics. 2015;16(5):319–26.
5. Wang Y, Zhang Y, Yang T, Zhao W, Wang N, Li P, Zeng X, Zhang W. Long
non-coding RNA MALAT1 for promoting metastasis and proliferation by
acting as a ceRNA of miR-144-3p in osteosarcoma cells. Oncotarget. 2017;
8(35):59417–34.
6. Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim
Biophys Acta. 2014;1839(11):1097–109.
7. Li Z, Tang Y, Xing W, Dong W, Wang Z. LncRNA, CRNDE promotes
osteosarcoma cell proliferation, invasion and migration by regulating
Notch1 signaling and epithelial-mesenchymal transition. Exp Mol Pathol.
2017;104(1):19–25.
8. Liu H, Zhou G, Fu X, Cui H, Pu G, Xiao Y, Sun W, Dong X, Zhang L, Cao S, Li
G, Wu X, Yang X. Long noncoding RNA TUG1 is a diagnostic factor in lung
adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX.
Oncotarget. 2017;8(60):101899–910.
9. Tang WG, Hu B, Sun HX, Sun QM, Sun C, Fu PY, Yang ZF, Zhang X, Zhou
CH, Fan J, Ren N, Xu Y. Long non-coding RNA00364 represses
hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2
signaling axis. Oncotarget. 2017;8(60):102006–19.
10. Wang K, Jin W, Song Y, Fei X. LncRNA RP11-436H11.5, functioning as a
competitive endogenous RNA, upregulates BCL-W expression by sponging
miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
Mol Cancer. 2017;16(1):166.
11. Yoon JH, You BH, Park CH, Kim YJ, Nam JW and Lee SK. The long
noncoding RNA LUCAT1 promotes tumorigenesis by controlling
ubiquitination and stability of DNA methyltransferase 1 in esophageal
squamous cell carcinoma. Cancer letters. 2018;417:47–57.
12. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the
Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–8.
13. Wang Y, Wang N, Zeng X, Sun J, Wang G, Xu H, Zhao W. MicroRNA-335 and
its target Rock1 synergistically influence tumor progression and prognosis
in osteosarcoma. Oncol Lett. 2017;13(5):3057–65.
14. Wang Y, Zhao W, Fu Q. miR-335 suppresses migration and invasion by
targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013;384(1–
2):105–11.
15. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu
NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time
quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;
33(20):e179.
16. Wang Y, Yang T, Liu Y, Zhao W, Zhang Z, Lu M, Zhang W. Decrease of miR-195
promotes chondrocytes proliferation and maintenance of chondrogenic
phenotype via targeting FGF-18 pathway. Int J Mol Sci. 2017;18(5). https://doi.
org/10.3390/ijms18050975.
17. Cai H, Liu X, Zheng J, Xue Y, Ma J, Li Z, Xi Z, Li Z, Bao M, Liu Y. Long non-
coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis
through inhibiting microRNA-299 in human glioblastoma. Oncogene. 2017;
36(3):318–31.
18. Huang J, Shi Y, Li H, Yang M, Liu G. MicroRNA-144 acts as a tumor
suppressor by targeting Rho-associated coiled-coil containing protein kinase
1 in osteosarcoma cells. Mol Med Rep. 2015;12(3):4554–9.
19. Ell B, Kang Y. MicroRNAs as regulators of bone homeostasis and bone
metastasis. Bonekey Rep. 2014;3:549.
20. Kafchinski LA, Jones KB. MicroRNAs in osteosarcomagenesis. Adv Exp Med
Biol. 2014;804:119–27.
21. Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. MicroRNAs and potential
targets in osteosarcoma: review. Front Pediatr. 2015;3:69.
22. Cai L, Lv J, Zhang Y, Li J, Wang Y, Yang H. The lncRNA HNF1A-AS1 is a
negative prognostic factor and promotes tumorigenesis in osteosarcoma. J
Cell Mol Med. 2017;21(11):2654–62.
23. Jia D, Niu Y, Li D, Liu Z. LncRNA C2dat1 promotes cell proliferation,
migration, and invasion by targeting MiR-34a-5p in osteosarcoma cells.
Oncol Res. 2017; https://doi.org/10.3727/096504017X15024946480113.
24. Li N, Sun ZH, Fang M, Xin JY, Wan CY. Long non-coding RNA ZFAS1
sponges miR-486 to promote osteosarcoma cells progression and
metastasis in vitro and vivo. Oncotarget. 2017;8(61):104160–70.
25. Yang C, Wang G, Yang J, Wang L. Long noncoding RNA NBAT1 negatively
modulates growth and metastasis of osteosarcoma cells through
suppression of miR-21. Am J Cancer Res. 2017;7(10):2009–19.
26. Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, Yang Y, Liu H, Wang
ZG, Xu QG, Fan J, Liu L, Sun SH, Zhou WP. Long noncoding RNA DANCR
increases stemness features of hepatocellular carcinoma by derepression of
CTNNB1. Hepatology (Baltimore, Md). 2016;63(2):499–511.
27. Jia J, Li F, Tang XS, Xu S, Gao Y, Shi Q, Guo W, Wang X, He D, Guo P. Long
noncoding RNA DANCR promotes invasion of prostate cancer through
epigenetically silencing expression of TIMP2/3. Oncotarget. 2016;7(25):
37868–81.
28. Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu J, Miao N, Shen J, Peng T. lncRNA DANCR
promotes tumor progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 2017;405:46–55.
29. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G,
Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y,
Lassmann T, Carninci P, et al. The GENCODE v7 catalog of human long
noncoding RNAs: analysis of their gene structure, evolution, and expression.
Genome Res. 2012;22(9):1775–89.
30. Chen DL, Lu YX, Zhang JX, Wei XL, Wang F, Zeng ZL, Pan ZZ, Yuan YF,
Wang FH, Pelicano H, Chiao PJ, Huang P, Xie D, Li YH, Ju HQ, Xu RH. Long
Wang et al. Molecular Cancer  (2018) 17:89 Page 13 of 14
non-coding RNA UICLM promotes colorectal cancer liver metastasis by
acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Theranostics. 2017;7(19):4836–49.
31. Li H, Chen S, Liu J, Guo X, Xiang X, Dong T, Ran P, Li Q, Zhu B, Zhang X,
Wang D, Xiao C, Zheng S. Long non-coding RNA PVT1-5 promotes cell
proliferation by regulating miR-126/SLC7A5 axis in lung cancer. Biochem
Biophys Res Commun. 2017; https://doi.org/10.1016/j.bbrc.2017.12.114.
32. Lin J, Shi Z, Yu Z, He Z. LncRNA HIF1A-AS2 positively affects the progression
and EMT formation of colorectal cancer through regulating miR-129-5p and
DNMT3A. Biomed Pharmacother. 2017;98:433–9.
33. Ma J, Fan Y, Feng T, Chen F, Xu Z, Li S, Lin Q, He X, Shi W, Liu Y, Cao X, Zhu
B, Liu Z. HOTAIR regulates HK2 expression by binding endogenous miR-125
and miR-143 in oesophageal squamous cell carcinoma progression.
Oncotarget. 2017;8(49):86410–22.
34. Xie CR, Wang F, Zhang S, Wang FQ, Zheng S, Li Z, Lv J, Qi HQ, Fang QL,
Wang XM, Yin ZY. Long noncoding RNA HCAL facilitates the growth and
metastasis of hepatocellular carcinoma by acting as a ceRNA of LAPTM4B.
Mol Ther Nucleic Acids. 2017;9:440–51.
35. Yang T, Zhou H, Liu P, Yan L, Yao W, Chen K, Zeng J, Li H, Hu J, Xu H, Ye Z.
lncRNA PVT1 and its splicing variant function as competing endogenous
RNA to regulate clear cell renal cell carcinoma progression. Oncotarget.
2017;8(49):85353–67.
36. Zhao L, Liu B. Identification of potential prognostic ceRNA module
biomarkers in patients with pancreatic adenocarcinoma. Oncotarget. 2017;
8(55):94493–504.
37. Wang Y, Yang T, Zhang Z, Lu M, Zhao W, Zeng X, Zhang W. Long non-
coding RNA TUG1 promotes migration and invasion by acting as a ceRNA
of miR-335-5p in osteosarcoma cells. Cancer Sci. 2017;108(5):859–67.
38. Li CH, Yu TB, Qiu HW, Zhao X, Zhou CL, Qi C. miR-150 is downregulated in
osteosarcoma and suppresses cell proliferation, migration and invasion by
targeting ROCK1. Oncol Lett. 2017;13(4):2191–7.
39. Liu Y, Liu J, Wang L, Yang X, Liu X. MicroRNA195 inhibits cell proliferation,
migration and invasion in laryngeal squamous cell carcinoma by targeting
ROCK1. Mol Med Rep. 2017;16(5):7154–62.
40. Qin Z, Wei X, Jin N, Wang Y, Zhao R, Hu Y, Yan W, Li J, Zhou Q. MiR-199a
targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
Artif Cells Nanomed Biotechnol. 2017:1–6. https://doi.org/10.1080/21691401.
2017.1396224.
41. Zhan Y, Zheng N, Teng F, Bao L, Liu F, Zhang M, Guo M, Guo W, Ding G,
Wang Q. MiR-199a/b-5p inhibits hepatocellular carcinoma progression by
post-transcriptionally suppressing ROCK1. Oncotarget. 2017;8(40):67169–80.
42. Han C, Wang W. MicroRNA-129-5p suppresses cell proliferation, migration
and invasion via targeting ROCK1 in osteosarcoma. Mol Med Rep. 2018;
17(3):4777–84.
43. Maskey N, Li D, Xu H, Song H, Wu C, Hua K, Song J, Fang L. MicroRNA-340
inhibits invasion and metastasis by downregulating ROCK1 in breast cancer
cells. Oncol Lett. 2017;14(2):2261–7.
44. Wu S, Ai N, Liu Q, Zhang J. MicroRNA448 inhibits the progression of
retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT
signalling pathway. Oncol Rep. 2018;39(5):2402–12.
Wang et al. Molecular Cancer  (2018) 17:89 Page 14 of 14
